Skip to content

OPIANT PHARMACEUTICALS, INC.: filings

Every OPIANT PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filing record ends 2022-11-14

The latest filing in this captured record is a 10-Q filed 2022-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. OPIANT PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-11-14fiscal Q3 2022421250001385508-22-000131
10-Q2022-08-11fiscal Q2 2022421210001385508-22-000121
10-Q2022-05-10fiscal Q1 202239830001385508-22-000054
10-K2022-03-15fiscal FY 202140820001385508-22-000038
10-Q2021-11-12fiscal Q3 2021411250001385508-21-000148
10-Q2021-08-05fiscal Q2 2021411210001385508-21-000105
10-Q2021-05-11fiscal Q1 202135740001385508-21-000066
10-K2021-03-04fiscal FY 202038790001385508-21-000035
10-Q2020-11-12fiscal Q3 2020371130001385508-20-000108
10-Q2020-08-06fiscal Q2 2020361080001385508-20-000094
10-Q2020-05-12fiscal Q1 202030650001385508-20-000057
10-K2020-03-04fiscal FY 201934700001385508-20-000039
10-Q2019-11-12fiscal Q3 2019351080001385508-19-000109
10-Q2019-08-08fiscal Q2 201932980001385508-19-000084
10-Q2019-05-09fiscal Q1 201925540001385508-19-000052
10-K2019-03-21fiscal FY 2018311040001385508-19-000028
10-Q2018-11-07fiscal Q3 201825700001385508-18-000108
10-Q2018-08-09fiscal Q2 201829870001385508-18-000068
10-Q2018-05-08fiscal Q1 201825520001385508-18-000037
10-Q2017-12-04fiscal Q1 201824500001628280-17-012095
10-K2017-10-13fiscal FY 201732650001144204-17-052467
10-Q2017-06-14fiscal Q3 201728820001144204-17-032535
10-Q2017-03-15fiscal Q2 201726780001144204-17-014770
10-Q2016-12-15fiscal Q1 201722460001144204-16-139775
10-K2016-10-28fiscal FY 201624510001144204-16-130283
10-Q2016-06-08fiscal Q3 201628830001144204-16-107498
10-Q2016-03-15fiscal Q2 201626810001144204-16-088190
10-Q2015-12-14fiscal Q1 201620420001144204-15-070627
10-K2015-10-26fiscal FY 201522460001144204-15-060795
10-Q2015-06-12fiscal Q3 201520540001144204-15-036837
10-Q2015-03-17fiscal Q2 201521580001144204-15-016749
10-Q2014-12-09fiscal Q1 201521430001144204-14-072939
10-K2014-10-27fiscal FY 201422450001144204-14-063064
10-Q2014-06-10fiscal Q3 201420790001144204-14-036713
10-Q2014-03-17fiscal Q2 201420780001144204-14-015949
10-Q2013-12-16fiscal Q1 201420640001144204-13-067349
10-K2013-10-29fiscal FY 201325760001144204-13-057387
10-Q2013-06-14fiscal Q3 201324980001144204-13-035032
10-Q2013-03-18fiscal Q2 2013281150001185185-13-000533
10-Q2012-12-20fiscal Q1 201329920001185185-12-002834
10-K/A2012-11-01fiscal FY 201227790001185185-12-002354
10-Q2012-06-14fiscal Q3 2012271040001185185-12-001341
10-Q2012-03-16fiscal Q2 2012271030001185185-12-000402
10-Q2011-12-15fiscal Q1 201227800001185185-11-002229

Inspect the source

Entity
OPIANT PHARMACEUTICALS, INC. / CIK 0001385508
Captured
SEC response SHA-256
2364e629461ca2a795db263ee8044ac545282f6ca3e3ea28eb9ce90156d0a955

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001385508.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))